Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...

Samuel recreated this phenomenon in a lab to prove that it occurs during actual plasmid transfer between bacteria. “We used plasmids that confer antibiotic resistance and introduced them into bacteria ...

2.5 Establishment of BCoV CRISPR/Cas13a assay combined RT-RAA The BCoV-Cas13a assays combined RT-RAA reaction and LwCas13a trans-cleavage system containing T7 transcription were established. For ...

Frizzled (FZD) proteins are the principal receptors of the Wnt signaling pathway. However, whether Wnt ligands induce FZD endocytosis and degradation remains elusive. The transmembrane E3 ubiquitin ...

“CLIC has already established an academic manufacturing network for a CD19 CAR-T, with centralised plasmid and vector production ... results from gene-editing technologies such as TALEN and ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

High CDC20 expression promotes aneuploid cancer cell sensitivity to spindle assembly checkpoint (SAC) inhibition by ...

Epidermal growth factor receptor (EGFR) is a major driver of cancer dissemination and target for anti-cancer therapies but ...